Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dana M Brantley

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Cancer Research|December 15, 2010
Angiocrine factors modulate tumor proliferation and motility through EphA2 repression of Slit2 tumor suppressor function in endotheliumDana M Brantley-Sieders, Charlene M Dunaway, Meghana Rao, et al.
Cancer Research|February 3, 2016
The Ephrin-A1/EPHA2 Signaling Axis Regulates Glutamine Metabolism in HER2-Positive Breast CancerVictoria M Youngblood, Laura C Kim, Deanna N Edwards, et al.
The Journal of Clinical Investigation|December 15, 2007
The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signalingDana M Brantley-Sieders, Guanglei Zhuang, Donna Hicks, et al.
Journal of the National Cancer Institute|July 26, 2012
Effects of cancer-associated EPHA3 mutations on lung cancerGuanglei Zhuang, Wenqiang Song, Katherine Amato, et al.
Oncogene|October 9, 2002
Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivoDana M Brantley, Nikki Cheng, Erin J Thompson, et al.
The Journal of Clinical Investigation|June 19, 2002
Blockade of TGF-beta inhibits mammary tumor cell viability, migration, and metastasesRebecca S Muraoka, Nancy Dumont, Christoph A Ritter, et al.
JCI Insight|August 8, 2020
Selective inhibition of mTORC1 in tumor vessels increases antitumor immunityShan Wang, Ariel Raybuck, Eileen Shiuan, et al.
The Journal of Clinical Investigation|September 25, 2014
Efferocytosis produces a prometastatic landscape during postpartum mammary gland involutionJamie C Stanford, Christian Young, Donna Hicks, et al.
Plos One|October 26, 2016
LIM-Only Protein 4 (LMO4) and LIM Domain Binding Protein 1 (LDB1) Promote Growth and Metastasis of Human Head and Neck Cancer (LMO4 and LDB1 in Head and Neck Cancer)Elizabeth A Simonik, Ying Cai, Katherine N Kimmelshue, et al.
Molecular Cancer Therapeutics|October 9, 2020
Repurposing of a Thromboxane Receptor Inhibitor Based on a Novel Role in Metastasis Identified by Phenome-Wide Association StudyThomas A Werfel, Donna J Hicks, Bushra Rahman, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Cancer Research|December 15, 2010
Angiocrine factors modulate tumor proliferation and motility through EphA2 repression of Slit2 tumor suppressor function in endotheliumDana M Brantley-Sieders, Charlene M Dunaway, Meghana Rao, et al.
Cancer Research|February 3, 2016
The Ephrin-A1/EPHA2 Signaling Axis Regulates Glutamine Metabolism in HER2-Positive Breast CancerVictoria M Youngblood, Laura C Kim, Deanna N Edwards, et al.
The Journal of Clinical Investigation|December 15, 2007
The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signalingDana M Brantley-Sieders, Guanglei Zhuang, Donna Hicks, et al.
Journal of the National Cancer Institute|July 26, 2012
Effects of cancer-associated EPHA3 mutations on lung cancerGuanglei Zhuang, Wenqiang Song, Katherine Amato, et al.
Oncogene|October 9, 2002
Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivoDana M Brantley, Nikki Cheng, Erin J Thompson, et al.
The Journal of Clinical Investigation|June 19, 2002
Blockade of TGF-beta inhibits mammary tumor cell viability, migration, and metastasesRebecca S Muraoka, Nancy Dumont, Christoph A Ritter, et al.
JCI Insight|August 8, 2020
Selective inhibition of mTORC1 in tumor vessels increases antitumor immunityShan Wang, Ariel Raybuck, Eileen Shiuan, et al.
The Journal of Clinical Investigation|September 25, 2014
Efferocytosis produces a prometastatic landscape during postpartum mammary gland involutionJamie C Stanford, Christian Young, Donna Hicks, et al.
Plos One|October 26, 2016
LIM-Only Protein 4 (LMO4) and LIM Domain Binding Protein 1 (LDB1) Promote Growth and Metastasis of Human Head and Neck Cancer (LMO4 and LDB1 in Head and Neck Cancer)Elizabeth A Simonik, Ying Cai, Katherine N Kimmelshue, et al.
Molecular Cancer Therapeutics|October 9, 2020
Repurposing of a Thromboxane Receptor Inhibitor Based on a Novel Role in Metastasis Identified by Phenome-Wide Association StudyThomas A Werfel, Donna J Hicks, Bushra Rahman, et al.
Pageof 5